April 25, 2023
Correction
Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis
First publishedApril 25, 2023,
DOI: https://doi.org/10.1212/WNL.0000000000207433
Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis
半岛投注体育官网
Apr 2023,
10.1212/WNL.0000000000207433;
DOI:10.1212/WNL.0000000000207433
Citation Manager Formats
Make Comment
See Comments
This is a PDF-only article. The first page of thePDFof this article appears above.
Letters: Rapid online correspondence
没有出版的评论ished for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to ourSubmission Siteto add or update your Disclosure information.
Your co-authors must send a completedPublishing Agreement Formto半岛投注体育官网Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.